Developing a COVID vaccine is just the first hurdle. A second wave of Covid-19 unfurling across parts of the world is focusing on minds even more acutely on the urgency of finding a viable vaccine. There are hundreds of vaccine candidates and 10 are in phase three trials.
It is a frantic scramble, that has exposed the best and the worst in us. Covid-19 and the search for a vaccine have laid bare nationalistic tendencies and brutally exposed the inequity underpinning access to health.
Serious and legitimate questions are also being raised over whether some nations are disregarding safety standards in a bid to be the first to develop the jab. Yet in the midst of all of this we are reminded of the selfless excellence of our scientists, and burgeoning solidarity shown by some, who reminds us we are in the same boat, rich and poor, and, that for this to work, we all need protection.
Isabelle Kumar moderated a panel in partnership with the World Economic Forum. Opening remarks were made by Professor Klaus Schwab, Executive Chairman of the World Economic Forum. She then discussed the challenges of making a vaccine globally available with the following experts.
Richard Hatchett, Chief Executive Officer, Coalition for Epidemic Preparedness and Innovations (CEPI), Norway – one of the WHO partners on COVAX
Julie Gerberding is an American infectious disease expert and the former director of the U.S. Centers for Disease Control – now Executive Vice-President and chief Patient officer at MERCK
Seth Berkley, CEO, Gavi, the Vaccine Alliance and COVAX partner
Sai Prasad, President, Developing Countries Vaccine Manufacturers Network
Heidi Larson, Professor of Anthropology, Director of The Vaccine Confidence Project
Tune in here to watch the discussion live from 18:30-19:15 CET on September 24.
Subscribe to our channel:
Watch our LIVE here:
Subscribe to our thematic channels:
Follow us on all platforms and on all devices:
Euronews is available on YouTube in 12 languages:
#Coronavirus #WFE #CoronavirusVaccine